| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |